Companies: 10,795·Total market cap: $144.5T
RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZBNASDAQHealthcare
$62.49
+$0.01(+0.02%)
Market Cap$3.8B
P/E Ratio—
52W High$62.51
52W Low$17.95
Overview

RayzeBio, Inc. Common Stock（RYZB）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ryzb · 股价预测 · 1 位分析师（近3月）· FMP · 更新于 2024年6月4日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

SellBuy

Hold

1 位分析师

共识

评级分布

Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
合计: 1 · 买入占比: 0.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $62.49

RayzeBio, Inc. Common Stock（RYZB）的分析师共识为 Hold，基于过去 3 个月内 1 位华尔街分析师的评级。RYZB 的 12 个月平均目标价为 $0.00，相对当前价 $62.49 代表 +0.0% 的潜在上行空间。

短期股价预测

⚠️ 短期模型暂不可用——近期成交量过低，信号不可靠。

长期股价预测

⚠️ 长期模型暂不可用——成交量过低，信号不可靠。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%43%7%
7Buy
6Neutral
1Sell
RSI (14)81.8Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · RYZB · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$62.49BUY
MA 10$62.49BUY
MA 20$62.43BUY
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $RYZB · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$62.49BUY
EMA 10$62.47BUY
EMA 20$62.40BUY
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $RYZB · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
William Blair2023-12-26
Downgrade ↓
Outperform→Market Perform

Wall Street analysts have recently issued updated ratings on RayzeBio, Inc. Common Stock (RYZB) stock. Of the recent 1 rating actions, 0 were upgrades and 1 were downgrades. 1 analysts currently cover RYZB.

分析师推荐趋势

Buy ratings0 → 0
Hold ratings1 → 1
Sell ratings0 → 0

RYZB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RYZB EPS of $— for the current fiscal year, based on estimates from 0 analysts. The RYZB revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

RYZB 股价预测由两类独立数据源支撑：来自 1 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RYZB 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。

RayzeBio, Inc. Common Stock 在 NASDAQ 上市，代码 RYZB。RYZB 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

RYZB 预测 · 8 个问题

根据 1 位华尔街分析师，RYZB 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $62.49，隐含约 +0.0% 的上行空间。

RYZB 目标价RYZB 分析师目标价RYZB 12个月目标价目标价 RYZB

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.